NVCR · NovoCure Ltd
$15.19
-1.12 (-6.87%)
At close · Jul 29
Market Cap
$1.90B
Shares
116.45M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ashley Cordova | CEO | $13,198,354 |
| Frank Leonard | CEO | $6,975,329 |
| Uri Weinberg | Chief Medical Officer | $4,159,945 |
| Nicholas Leupin | Former Chief Medical Officer | $3,999,041 |
| Michael Puri | Chief Human Resources Officer | $3,933,893 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ashley Cordova | CFO | $6,091,704 |
| Frank Leonard | CEO | $5,823,930 |
| Uri Weinberg | Chief Medical Officer | $5,055,906 |
| Barak Ben-Arye General Counsel | — | $4,799,381 |
| Asaf Danziger | CEO | $1,539,088 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ashley Cordova | CFO | $6,317,066 |
| Wilhelmus Groenhuysen | COO | $5,967,665 |
| Pritesh Shah | Chief Commercial Officer | $5,180,138 |
| Frank Leonard | CEO | $5,039,237 |
| Barak Ben-Arye General Counsel | — | $4,863,644 |
| Asaf Danziger | CEO | $1,521,026 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ashley Cordova | CFO | $6,842,664 |
| Wilhelmus Groenhuysen | COO | $6,624,282 |
| Pritesh Shah | Chief Commercial Officer | $6,316,633 |
| Asaf Danziger | CEO | $2,278,951 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Wilhelmus Groenhuysen | COO | $6,386,961 |
| Pritesh Shah | Chief Commercial Officer | $5,506,894 |
| Ashley Cordova | CFO | $5,484,444 |
| Todd Longsworth General Counsel | — | $5,236,783 |
| Asaf Danziger | CEO | $1,160,236 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William Doyle | Chairman | $15,723,701 |
| Asaf Danziger | CEO | $8,956,704 |
| Wilhelmus Groenhuysen | COO | $6,937,924 |
| Pritesh Shah | Chief Commercial Officer | $5,940,598 |
| Todd Longsworth General Counsel | — | $5,149,372 |
| Ashley Cordova | CFO | $3,243,249 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William Doyle | Chairman | $8,286,101 |
| Asaf Danziger | CEO | $7,316,607 |
| Michael Ambrogi | COO | $4,676,264 |
| Wilhelmus Groenhuysen | COO | $4,196,084 |
| Pritesh Shah | Chief Commercial Officer | $3,673,933 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Asaf Danziger | CEO | $4,570,294 |
| William Doyle | Chairman | $4,558,655 |
| Wilhelmus Groenhuysen | COO | $3,459,217 |
| Pritesh Shah | Chief Commercial Officer | $3,070,496 |
| Michael Ambrogi | COO | $2,611,707 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| William Doyle | Chairman | $23,774,648 |
| Asaf Danziger | CEO | $4,311,588 |
| Wilhelmus Groenhuysen | CFO | $3,117,082 |
| Michael Ambrogi | COO | $2,254,551 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| William Vernon | director | Appointed | 2026-06-05 |
| Kristin Stafford | director | Appointed | 2026-06-05 |
| Timothy Scannell | director | Appointed | 2026-06-05 |
| Allyson Ocean | director | Appointed | 2026-06-05 |
| Martin Madden | director | Appointed | 2026-06-05 |
| Kinyip Gabriel Leung | director | Appointed | 2026-06-05 |
| Frank Leonard | director | Appointed | 2026-06-05 |
| David Hung | director | Appointed | 2026-06-05 |
| Jeryl Hilleman | director | Appointed | 2026-06-05 |
| William Doyle | director | Appointed | 2026-06-05 |
| Asaf Danziger | director | Appointed | 2026-06-05 |
Key facts
CIK
1645113
CUSIP
G6674U108
13F (30d)
57 filings
34 filers
Visit website
Investor relations